Medical Oncology

Uzm. Dr. Alper Türkel

Doctor and researcher Eskişehir Şehir Hastanesi Eskişehir
Breast Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • InstitutionEskişehir Şehir Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 12 publications · Model version —From source
  • Publications36 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0001-5071-9679ORCIDFrom source
  • Last synchronised7 November 2026 00:21https://eskisehirsehir.saglik.gov.tr/TR-604583/doktorlarimiz.html#alper-turkelsaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

36 publications

  1. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33060365 PMID 42346265 Open-access full textSource: OpenAlex

  2. Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) Study

    Clinical Breast Cancer, 2026

    DOI 10.1016/j.clbc.2025.11.014 PMID 41456513 Source: ORCID

  3. Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

    Cancers, 2026

    DOI 10.3390/cancers18142302 PMID 42512369 Open-access full textSource: ORCID

  4. Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer

    Journal of Oncology Pharmacy Practice, 2026

    DOI 10.1177/10781552231156521 PMID 36760158 11 citations (OpenAlex) Source: ORCID

  5. Clinical significance of the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score as a prognostic indicator in early-stage colon cancer

    Discover Oncology, 2026

    DOI 10.1007/s12672-026-05706-6 Open-access full textSource: ORCID

  6. Evaluation of the Prognostic Importance of Gustave Roussy Immune Score in Hepatocellular Cancer Etiological Subtypes

    Turkish Journal of Clinics and Laboratory, 2026

    DOI 10.18663/tjcl.1810106 Open-access full textSource: ORCID

  7. Distinct fatigue profiles and psychological mechanisms among breast cancer survivors: A latent profile and mediation analysis

    Dusunen Adam The Journal of Psychiatry and Neurological Sciences, 2026

    DOI 10.14744/dajpns.2026.00322 PMID 42460117 Open-access full textSource: OpenAlex

  8. PRR11 expression in early ER+/HER2‑low breast cancer: Association with estrogen receptor positivity and exploratory analysis of prognostic significance

    Oncology Letters, 2026

    DOI 10.3892/ol.2026.15766 PMID 42500608 Open-access full textSource: OpenAlex

  9. Predictors of burnout and secondary traumatic stress in medical oncologists: the role of empathy and dispositional mindfulness

    BMC Health Services Research, 2026

    DOI 10.1186/s12913-026-14002-6 PMID 41501812 Open-access full textSource: OpenAlex

  10. Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group

    International Journal of Cancer, 2025

    DOI 10.1002/ijc.70213 PMID 41147655 3 citations (Europe PMC) Source: OpenAlex

View all 36 publications